Chris Grainger

Chris Grainger has extensive experience in vaccine formulation and drug product development, currently serving as the Executive Director at Vaxcyte since September 2017, following a progression from Senior Director to Director in Vaccine Formulation and Drug Product Development. Prior experience includes over a decade at Pfizer, where Chris held positions including Senior Principal Scientist and Principal Scientist, leading teams focused on early research and preclinical vaccine formulations across various disease types. Academic involvement features a visiting lecturer role at King's College London and a PhD in inhaled toxicology and permeability from the same institution. Chris's career also includes contributions at MedImmune and Quadrant Healthcare, where innovative work on inhaled vaccine systems and a live measles vaccine was performed. Education includes a BSc in Microbiology from the University of Nottingham.